| For: | Yu H, Zhang F, He YC, Zhang LS. Quality by design strategy of human mesenchymal stem/stromal cell drug products for the treatment of knee osteoarthritis. World J Stem Cells 2025; 17(5): 106547 [PMID: 40503368 DOI: 10.4252/wjsc.v17.i5.106547] |
|---|---|
| URL: | https://www.wjgnet.com/1948-0210/full/v17/i5/106547.htm |
| Number | Citing Articles |
| 1 |
Lei Zhang. Mesenchymal Stem Cells - Biology, Therapeutics, and Beyond. Biochemistry 2025; 69 doi: 10.5772/intechopen.1012366
|
| 2 |
Noura A A Ebrahim, Thoraya A Farghaly, Ghada S Masaret, Amani M R Alsaedi, Soliman M A Soliman. From laboratory to clinic: Bridging regulatory and manufacturing gaps in stem cell-based therapies. World Journal of Stem Cells 2026; 18(5): 117591 doi: 10.4252/wjsc.v18.i5.117591
|
| 3 |
Nada Khairi Younis, Hayder Naji Sameer, Hasanain Amer Naji, M. M. Rekha, Laxmidhar Maharana, Anima Nanda, Vipasha Sharma, Ashish Singh Chauhan, Rasim M. Salih, Mohaned Adil, Farzaneh Yazdi. A comparative analysis of MSCs and their exosomes in osteoarthritis therapy: complementary roles and clinical translation. Immunopharmacology and Immunotoxicology 2026; doi: 10.1080/08923973.2026.2673950
|